Literature DB >> 15556817

Localization and quantification of mitral valve prolapse using three-dimensional echocardiography.

A Delabays1, X Jeanrenaud, P-G Chassot, L K Von Segesser, L Kappenberger.   

Abstract

AIMS: Mitral valve prolapse is a common source of severe mitral regurgitation in Western countries. Three-dimensional echocardiography can provide views of the entire valve, allowing a complete assessment of the valve leaflets and commissures. It has the potential to precisely locate and quantify mitral valve prolapse. METHODS AND
RESULTS: Between January 1997 and December 2000, 91 patients with severe mitral regurgitation due to mitral valve prolapse underwent a transesophageal echocardiography with three-dimensional reconstruction of the mitral valve as part of their pre-operative work-up. The location and extent of the prolapse by echo was compared to the surgical status. The volume of prolapsing leaflet was calculated and compared to the volume of resected tissue whenever a repair was attempted. There was an excellent correspondence between the echographic localization of the prolapse and surgical inspection, and between the volume of prolapsing and surgically resected tissue (r=0.94, p<0.0001).
CONCLUSIONS: In patients with severe mitral regurgitation due to mitral valve prolapse, 3D echo allowed a precise localization and an accurate quantification of the prolapsing portion of the leaflets. This technique can provide refinements in the surgical planning of mitral valve repair and in the selection of candidates for this intervention.

Entities:  

Mesh:

Year:  2004        PMID: 15556817     DOI: 10.1016/j.euje.2004.03.007

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  9 in total

1.  Mitral valve analysis using a novel 3D holographic display: a feasibility study of 3D ultrasound data converted to a holographic screen.

Authors:  Jan Otto Beitnes; Lars Gunnar Klæboe; Jørn Skaarud Karlsen; Stig Urheim
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-13       Impact factor: 2.357

2.  3D echo appearance of posterior leaflet prolapse due to chordae elongation.

Authors:  Umar Imran Hamid; Chris McConkey; Mehmood Jadoon; Harry Parissis; Alastair Graham
Journal:  BMJ Case Rep       Date:  2011-09-08

Review 3.  Quantitative assessment of mitral insufficiency: its advantages and disadvantages.

Authors:  Anna Paszczuk; Susan E Wiegers
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

4.  Real-time three-dimensional transoesophageal echocardiography: a new intraoperative feasible and useful technology in cardiac surgery.

Authors:  Paola Gripari; Gloria Tamborini; Paolo Barbier; Anna C Maltagliati; Claudia A Galli; Manuela Muratori; Luca Salvi; Erminio Sisillo; Francesco Alamanni; Mauro Pepi
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-30       Impact factor: 2.357

Review 5.  Three-Dimensional Echocardiography Assessment of Right Ventricular Volumes and Function: Technological Perspective and Clinical Application.

Authors:  Ashfaq Ahmad; He Li; Yanting Zhang; Juanjuan Liu; Ying Gao; Mingzhu Qian; Yixia Lin; Luyang Yi; Li Zhang; Yuman Li; Mingxing Xie
Journal:  Diagnostics (Basel)       Date:  2022-03-25

Review 6.  Noninvasive imaging of the heart and coronary arteries.

Authors:  Amy M West; Christopher M Kramer
Journal:  Surg Clin North Am       Date:  2009-08       Impact factor: 2.741

7.  Three-dimensional echocardiography in valve disease.

Authors:  Chiara Colombo; Gloria Tamborini; Mauro Pepi; Marina Alimento; Cesare Fiorentini
Journal:  Heart Int       Date:  2007-06-15

Review 8.  Role of modern 3D echocardiography in valvular heart disease.

Authors:  Takahiro Shiota
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

9.  Finite-element-method (FEM) model generation of time-resolved 3D echocardiographic geometry data for mitral-valve volumetry.

Authors:  Janko F Verhey; Nadia S Nathan; Otto Rienhoff; Ron Kikinis; Fabian Rakebrandt; Michael N D'Ambra
Journal:  Biomed Eng Online       Date:  2006-03-03       Impact factor: 2.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.